Literature DB >> 20457435

CTX-M type extended spectrum beta-lactamases in Escherichia coli isolates from community acquired upper urinary tract infections at a university in the European part of Turkey.

Aygul Dogan Celik1, Zerrin Yulugkural, Figen Kuloglu, Cafer Eroglu, Sinem Torol, Haluk Vahaboğlu, Filiz Akata.   

Abstract

Extended spectrum beta-lactamase (ESBL) producing Escherichia coli has been an emerging etiologic agent in the community acquired infections. We investigated the occurrence of ESBL producing E. coli isolated from patients admitted with community acquired urinary tract infection (UTI) to the hospital of the Trakya University, Turkey during 2006. Eleven single patient isolates of E. coli harboring ESBL were identified among 30 E. coli isolated from patients admitted with symptoms corresponding to upper UTI. CTX-M type ESBLs were detected in all 11 ESBL-producers by isoelectric focusing and polymerase chain reaction screening. Sequence analysis revealed CTX-M-1 in one isolate, CTX-M-3 in three isolates and CTX-M-15 in seven isolates. ESBL-producing E. coli isolated from community acquired UTIs are widespread in the European part of Turkey. Copyright 2010 Taiwan Society of Microbiology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20457435     DOI: 10.1016/S1684-1182(10)60026-6

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  2 in total

1.  Phenotypic and genotypic comparison of ESBL production by vaginal Escherichia coli isolates from pregnant and non-pregnant women.

Authors:  Sareaa M G Al-Mayahie
Journal:  Ann Clin Microbiol Antimicrob       Date:  2013-04-25       Impact factor: 3.944

2.  Prevalence of Multidrug Resistance and Extended-Spectrum β-Lactamase Carriage of Clinical Uropathogenic Escherichia coli Isolates in Riyadh, Saudi Arabia.

Authors:  Abdulaziz Alqasim; Ahmad Abu Jaffal; Abdullah A Alyousef
Journal:  Int J Microbiol       Date:  2018-09-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.